choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Pramlintide

Pramlintide Newsletter
  • Cases of ‘Double Diabetes’ Rising: What to Know 09 Dec 2025 09:20 GMT

    diabetes. According to Type 1 Trial … determining appropriate treatment. The tests … diabetes, type 1 diabetes has very few approved medications: injectable or inhaled insulin and pramlintideamylin. GLP-1s for patients with type 1 diabetes are in clinical trials

  • Adjunctive Therapies Aim to Enhance Health in T1D 12 Dec 2025 12:10 GMT

    Insulin is the mainstay of treatments for type 1 diabetesinsulin.” However, a 2017 randomized clinical trialtrials will “hopefully strengthen the evidence in this area.” Targeting Insulin Pramlintide … about general health, medical research, mental health …

  • Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound 11 Nov 2025 04:47 GMT

    trials, and it works differently from GLP-1 medicines … in California. An existing drug mimicking amylin, pramlintide (Symlin) has been available … States for years as a diabetes treatment, Dr. Tan says. … is worry among obesity doctors that rapid weight loss …

  • Scientists outline how future therapies could change type 1 diabetes care 24 Sep 2025 22:24 GMT

    … new era of type 1 diabetes treatment is emerging, but only … Stage 3 trials (for example, the PROTECT trial) shows preservation … systems (such as insulin with glucagon or amylin analogs), and … inhibitors. However, only pramlintide is FDA-approved for T1D, and …

  • Multidisciplinary approach crucial when treating obesity in type 1 diabetes 11 Sep 2025 21:05 GMT

    pramlintide (Symlin, AstraZeneca) and metformin. Across trials of multiple medications, adults with type 1 diabetestrial, 18 adults with type 1 diabetesdrugs can be prescribed off-label. Bariatric surgery may be a treatment … for large insulin adjustments …

  • ADA 2025: Clinical Trial Data on Incretin Therapies 25 Jul 2025 20:38 GMT

    … all sorts of new drugs and older drugs, and a large amount … , as we had pramlintide. This takes that amylin analog and mixes it … obesity and type 2 diabetes.  The next trial is one that I … patients reported nausea. In the treatment group, nausea was reported in …

  • Diabetes Dialogue: GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025 21 Jul 2025 16:48 GMT

    … reductions, trials showed meaningful weight loss and insulin dose reductions … time-in-range and treatment burden. Isaacs and Bellini … 1 diabetes, despite widespread off-label use. In contrast, pramlintide … optimism about an upcoming trial of tirzepatide led by …

  • ADJUST-T1D Suggests Semaglutide Efficaciously Treats Type 1 Diabetes, with Viral Shah, MD 17 Jul 2025 17:19 GMT

    Diabetes and Metabolic Diseases at Indiana University School of Medicine … few alternative treatments for patients. The automated insulin delivery ( … only other drug that was approved was pramlintide, which … the type 2 diabetes trials or obesity trial, it sounds …

  • TandemAI and Perpetual Medicines Announce Strategic Merger to Expand Physics and AI-Based Drug Discovery Capabilities 10 Jul 2025 12:01 GMT

    … to reach clinical trials within the next … drugs in the U.S., including Byetta ® (exantide), Symlin ® (pramlintide … 47; About Perpetual Medicines Perpetual Medicines is a fully … RESEARCH SOFTWARE BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL SCIENCE ARTIFICIAL …

  • Top 10 Diabetes Medications: Managing Blood Sugar Levels 03 Jun 2025 10:21 GMT

    … Actos, Avandia Insulin: The Cornerstone of Diabetes Treatment Short-Acting Insulin Regular insulin, such as … other drugs? Yes, diabetes medications may interact with other medications, supplements, or herbal remedies, potentially …

Satisfied with the content?

Continue to create your account.